Cyclophilin A: promising new target in cardiovascular therapy.
about
Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular diseaseSuppression of coronavirus replication by cyclophilin inhibitorsThe roles of CD147 and/or cyclophilin A in kidney diseasesCyclophilin J is a novel peptidyl-prolyl isomerase and target for repressing the growth of hepatocellular carcinomaInflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.Molecular cloning, expression, and characterization of cyclophilin A from Clonorchis sinensis.Unraveling amyloid toxicity pathway in NIH3T3 cells by a combined proteomic and 1 H-NMR metabonomic approach.CD137-CD137L interaction regulates atherosclerosis via cyclophilin A in apolipoprotein E-deficient mice.Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: The Tianliao Old People (TOP) studyUrinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes MellitusImbalanced Production of Reactive Oxygen Species and Mitochondrial Antioxidant SOD2 in Fabry Disease-Specific Human Induced Pluripotent Stem Cell-Differentiated Vascular Endothelial Cells.Determination of the Full Catalytic Cycle among Multiple Cyclophilin Family Members and Limitations on the Application of CPMG-RD in Reversible Catalytic Systems.Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular CarcinomaDietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline.Rho-kinase: important new therapeutic target in cardiovascular diseases.Fragment informatics and computational fragment-based drug design: an overview and update.Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.Muscle characterization of reactive oxygen species in oral diseases.Glutathione peroxidase-deficient smooth muscle cells cause paracrine activation of normal smooth muscle cells via cyclophilin A.Identification of low abundance cyclophilins in human plasma.Cyclophilin A Interacts with Viral VP4 and Inhibits the Replication of Infectious Bursal Disease Virus.Functions of cyclophilin A in atherosclerosis.Salivary gland proteome of the human malaria vector, Anopheles campestris-like (Diptera: Culicidae).Alzheimer's disease: A breach in the blood-brain barrier.The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.Chemotactic activity of channel catfish, Ictalurus punctatus (Rafinesque), recombinant cyclophilin A.Angiotensin II upregulates cyclophilin A by enhancing ROS production in rat cardiomyocytesInterferon Regulatory Factor 9 Structure and Regulation
P2860
Q21246040-EFC3ECFF-25F0-414B-A0F6-117466BD1A78Q26825245-3E7E9244-318B-4F03-8EBD-E7826E9ED3B0Q28083416-5619327D-E813-47D5-95DC-2D8BACFFF89FQ28547553-6618EC5E-6336-492C-BBE8-E22548769395Q30524688-DD48B172-1F26-44AE-A0C5-D94896EFA070Q33832435-A52692F1-7FBA-4037-B37C-363AFF2409E2Q34495047-E408548B-27BC-45A5-93AA-D517B37CD7EAQ35092856-78B11A0D-D81C-474D-9997-721D94CFA51CQ35535488-D72C786F-D61B-4BC8-ACC0-25D7E96E5704Q36207045-C928E1FF-206A-4CC4-8B99-8EF6A4D76E65Q36219290-D7290A13-FF8C-464E-AB15-24828C9B0467Q36711119-36694163-B4B4-4642-A419-9061C016FACFQ37297666-9DD93E04-DD25-4D12-BBF7-CAB92B48C03FQ37384973-08F6A353-78DD-410A-A250-8E876C2E05CBQ37881804-B46469A5-3FA9-4F93-A134-E4D975CD8D55Q37995087-048CE2F7-2DD7-4061-AB2B-57CC399942E4Q37997003-786C9CF7-67F0-458D-B2F1-3F51D3B6499FQ38247764-F48A6C45-01F3-441A-BB75-096DCE625AB1Q39167570-A1ACD655-2EF4-41D3-963C-7CD4110206D5Q40469235-4C92FA5E-EF91-4256-82F6-9313AFCB1E9BQ41151315-86F9A6D5-A79C-47E7-A35A-FC5CEAC22CCAQ43081736-39159FA8-7B9D-4375-9131-B15F00B27C64Q44167434-2409FFA0-2903-4B71-A9B9-E83090731935Q48496560-77A4206C-9A26-45FE-9776-1B0FCA304EDCQ49641447-35B32AF2-7E49-43DC-A040-1A31348EDFA7Q51027272-174532F7-20BA-4E0E-B702-243A2F8FDC7EQ58764102-3B9F2609-8250-4706-8C28-AEAC40F40984Q58790092-DC2825EB-3C99-443F-9144-8A5A7CDB4414
P2860
Cyclophilin A: promising new target in cardiovascular therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclophilin A: promising new target in cardiovascular therapy.
@en
Cyclophilin A: promising new target in cardiovascular therapy.
@nl
type
label
Cyclophilin A: promising new target in cardiovascular therapy.
@en
Cyclophilin A: promising new target in cardiovascular therapy.
@nl
prefLabel
Cyclophilin A: promising new target in cardiovascular therapy.
@en
Cyclophilin A: promising new target in cardiovascular therapy.
@nl
P2093
P2860
P356
P1433
P1476
Cyclophilin A: promising new target in cardiovascular therapy.
@en
P2093
Bradford C Berk
Hiroaki Shimokawa
Kimio Satoh
P2860
P304
P356
10.1253/CIRCJ.CJ-10-0904
P577
2010-10-15T00:00:00Z